InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,867.60
(
-0.80%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.28
(
0.06%
)
Bitcoin
64,230.86
(
-0.08%
)
Post# of 2795
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

legalizeMJ

Send PM Follow Ignore
Followers 157
Posts 13346
Boards Moderated 0
Alias Born 04/30/2014

legalizeMJ

Re: mylar23 post# 2353

Thursday, 03/16/2017 11:30:33 AM

Thursday, March 16, 2017 11:30:33 AM

Post# of 2795
OCRX vs CLSN(liver cancer stcoks)

1)OCRX: Phase 2
2)CLSN: doing phase 3

http://www.marketwatch.com/story/celsion-corporation-reports-year-end-2016-financial-results-and-provides-business-update-2017-03-16

The Company's lead program is ThermoDox(R) which is currently in Phase III development for the treatment of primary liver cancer
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up